Armata Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
  • Armata Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$10.6M, a 39.8% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$47.4M, a 46% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$32.5M, a 37.8% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$23.6M, a 29% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.